MORGAN STANLEY - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 190 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$10,674,080
-11.2%
913,095
+2.1%
0.00%0.0%
Q2 2023$12,016,273
-49.3%
894,068
-37.4%
0.00%
-66.7%
Q1 2023$23,681,430
-26.7%
1,428,313
-17.8%
0.00%
-25.0%
Q4 2022$32,315,697
+61.0%
1,737,403
+11.1%
0.00%
+33.3%
Q3 2022$20,069,000
+97.3%
1,564,145
+7.8%
0.00%
+200.0%
Q2 2022$10,174,000
-1.1%
1,451,262
+16.9%
0.00%0.0%
Q1 2022$10,291,000
+473.6%
1,241,326
+368.2%
0.00%
Q4 2021$1,794,000
+52.7%
265,108
+19.6%
0.00%
Q3 2021$1,175,000
-40.8%
221,600
-35.8%
0.00%
Q2 2021$1,985,000
+370.4%
345,417
+277.4%
0.00%
Q1 2021$422,000
-24.0%
91,514
-44.9%
0.00%
Q4 2020$555,000
-93.3%
166,175
-94.0%
0.00%
-100.0%
Q3 2020$8,257,000
-36.6%
2,780,077
-1.4%
0.00%
-33.3%
Q2 2020$13,028,000
+24.8%
2,820,035
+4.0%
0.00%0.0%
Q1 2020$10,443,000
-2.7%
2,712,629
-5.3%
0.00%
+50.0%
Q4 2019$10,737,000
-23.4%
2,863,325
+8.4%
0.00%
-50.0%
Q3 2019$14,024,000
+44.8%
2,640,969
+4.7%
0.00%
+33.3%
Q2 2019$9,686,000
-17.9%
2,522,301
+9.1%
0.00%0.0%
Q1 2019$11,791,000
+89.0%
2,311,790
-28.9%
0.00%
+50.0%
Q4 2018$6,239,000
-5.5%
3,249,673
+86.0%
0.00%0.0%
Q3 2018$6,604,000
+21.5%
1,746,902
+0.3%
0.00%
+100.0%
Q2 2018$5,437,000
+91.9%
1,742,474
+47.0%
0.00%0.0%
Q1 2018$2,833,000
-14.9%
1,185,384
+39.3%
0.00%0.0%
Q4 2017$3,328,000
+261.7%
851,134
+133.2%
0.00%
Q3 2017$920,000
+237.0%
365,038
+269.6%
0.00%
Q2 2017$273,000
+162.5%
98,774
+87.5%
0.00%
Q1 2017$104,000
+300.0%
52,690
+112.1%
0.00%
Q4 2016$26,000
+1200.0%
24,838
+1025.4%
0.00%
Q3 2016$2,000
-60.0%
2,207
-66.7%
0.00%
Q2 2016$5,000
-44.4%
6,634
-10.8%
0.00%
Q1 2016$9,000
-85.9%
7,440
-71.1%
0.00%
Q4 2015$64,000
-54.9%
25,737
-45.6%
0.00%
Q3 2015$142,000
-90.7%
47,308
-87.2%
0.00%
-100.0%
Q2 2015$1,531,000
-54.1%
370,513
-51.9%
0.00%0.0%
Q1 2015$3,338,000
+69.9%
770,731
+16.5%
0.00%0.0%
Q4 2014$1,965,000
-52.1%
661,758
-46.5%
0.00%
-50.0%
Q3 2014$4,104,000
+58528.6%
1,236,179
+39007.2%
0.00%
Q1 2014$7,000
-58.8%
3,161
-63.7%
0.00%
Q4 2013$17,0008,7010.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 208,189$1,726,0003.48%
FRIESS ASSOCIATES LLC 571,940$4,741,0002.53%
GABLES CAPITAL MANAGEMENT INC. 438,764$3,637,0002.28%
Prairiewood Capital, LLC 258,073$2,139,0001.50%
Quantedge Capital Pte Ltd 597,300$4,952,0001.46%
ARMISTICE CAPITAL, LLC 8,372,000$69,404,0001.34%
SummerHaven Investment Management, LLC 158,473$1,314,0000.74%
Capital Impact Advisors, LLC 99,322$823,0000.60%
EAM Investors, LLC 365,415$3,029,0000.56%
GLOBEFLEX CAPITAL L P 304,515$2,524,0000.51%
View complete list of CATALYST PHARMACEUTICALS INC shareholders